Neogen Corp
NASDAQ:NEOG

Watchlist Manager
Neogen Corp Logo
Neogen Corp
NASDAQ:NEOG
Watchlist
Price: 9.42 USD -1.98% Market Closed
Market Cap: $2B

Neogen Corp
Investor Relations

Founded in 1982, Neogen Corp. has steadily carved out its niche at the intersection of food safety and animal health, positioning itself as a vital player in agricultural diagnostics. The company's journey began in Lansing, Michigan, where it initially focused on innovative solutions to meet the growing demands of food safety and quality testing. By developing rapid tests for detecting foodborne bacteria and allergens, Neogen tapped into a critical market, addressing the increasing concerns about food safety amidst a complex global supply chain. This foundation in diagnostics set the stage for the growth Neogen would see over the ensuing decades.

As Neogen expanded, it strategically diversified its offerings, moving beyond food safety into the broader realm of animal health. This expansion was not merely about developing products; it was about advancing the means by which farms and food producers monitor and ensure the health of their livestock and crops. The company's profits flow from the sale of its diagnostic products, which help minimize risks associated with food contamination and animal diseases. By providing a suite of solutions, from DNA testing for genetic traits and diseases in cattle to disinfectants and rodenticides that maintain farm hygiene, Neogen creates value for its clients by increasing their operational efficiency and safeguarding public health. This strategic blend of food safety and animal health products places Neogen at the heart of modern agricultural and food production systems, where safety and efficiency are paramount.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Apr 9, 2026
AI Summary
Q3 2026

Revenue: Neogen reported third-quarter revenue of $211.2 million, with core revenue up 0.1%, as Food Safety growth offset a significant setback in Animal Safety from supplier disruptions.

Margins: Adjusted EBITDA margin improved to 22.8%, one of the highest levels in recent company history, helped by cost control even though revenue was lower.

Guidance: Full-year fiscal 2026 revenue guidance was raised to $857 million to $860 million, while adjusted EBITDA guidance stayed at $175 million.

Animal Safety: Management said Animal Safety was hurt by third-party supplier problems tied to documentation, raw materials, site transitions, and tariff-related changes, and expects the issue to continue into Q4.

Food Safety: Food Safety posted another solid quarter with 4% core growth, led by indicator testing and culture media, and management said the segment remains on track with market growth.

Transformation: The company is pushing three priorities—commercial execution, product innovation, and operational efficiency—with Petrifilm manufacturing transition on schedule for November 2026 and an Investor Day planned for this fall.

Key Financials
Revenue
$211.2 million
Food Safety revenue
$156.7 million
Animal Safety revenue
$54.5 million
Gross margin
46.9%
Adjusted gross margin
51.7%
Adjusted EBITDA
$48.2 million
Adjusted EBITDA margin
22.8%
Adjusted net income
$19.4 million
Adjusted earnings per share
$0.09
Gross debt
$800 million
Cash
$159.9 million
Free cash flow
$11.1 million
Genomics sale price
$160 million
Genomics expected net proceeds
approximately $140 million
Net debt to adjusted EBITDA
below 3x
Freight and transportation cost increase
high single-digit to low double-digit range
Plastic OEM inventory coverage
6 to 9 months
Earnings Call Recording
Other Earnings Calls

Management

Mr. John Edward Adent
President, CEO & Director
No Bio Available
Mr. David H. Naemura
Chief Financial Officer
No Bio Available
Mr. Douglas E. Jones
COO & VP
No Bio Available
Ms. Amy M. Rocklin Ph.D.
Chief Legal & Compliance Officer and Corporate Secretary
No Bio Available
Mr. John Moylan
VP, Corporate Controller & Chief Accounting Officer
No Bio Available
Dr. Robert S. Donofrio Ph.D.
VP & Chief Scientific Officer
No Bio Available
Sarah Demey
Administrative Manager
No Bio Available
Mr. Bill Waelke
Head of Investor Relations
No Bio Available
Ms. Julie A. Mann
VP & Chief Human Resources Officer
No Bio Available

Contacts

Address
MICHIGAN
Lansing
620 Lesher Pl
Contacts
+15173729200.0
www.neogen.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett